Fructose malabsorption: True condition or a variance from normality

Journal of Clinical Gastroenterology

Volumn 45, Issue 1, 2011, Pages 16-21

  Kyaw, Moe Htet ^a   Mayberry, John Francis ^b  

^a Digestive Diseases Centre   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

breath test; fructose malabsorption; glucose; high fructose corn syrup; irritable bowel syndrome

Indexed keywords

CARBOHYDRATE; FRUCTOSE; GLUCOSE; SORBITOL;

ABSORPTION; ARTICLE; BIOCHEMISTRY; DIAGNOSTIC PROCEDURE; DIET; DIET THERAPY; DISEASE ASSOCIATION; FRUCTOSE MALABSORPTION; HUMAN; HYDROGEN BREATH TEST; IRRITABLE COLON; MALABSORPTION; PRIORITY JOURNAL;

ANIMALS; BREATH TESTS; DIETARY CARBOHYDRATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSE; HUMANS; IRRITABLE BOWEL SYNDROME; MALABSORPTION SYNDROMES;

EID: 78650956155     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181eed6bf     Document Type: Article

References (66)

1. Andersson DE, Nygren A. Four cases of long-standing diarrhoea and colic pains cured by fructose-free diet - a pathogenetic discussion. Acta Med Scand. 1978;203:87-92.
2. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006;106:1631-1639.
3. White JS. Straight talk about high-fructose corn syrup: what it is and what it ain't. Am J Clin Nutr. 2008;88:1716S-1721S.
4. Hanover LM, White JS. Manufacturing, composition, and applications of fructose1. Am J Clin Nutr. 1993;58(5 suppl): 724S-732S.
5. Duffey KJ, Popkin BM. High-fructose corn syrup: is this what's for dinner? Am J Clin Nutr. 2008;88:1722S-1732S.
6. Park YK, Yetley EA. Intakes and food sources of fructose in the United States. Am J Clin Nutr. 1993;58(5 suppl): 737S-747S.
7. Schultz SG, Strecker CK. Fructose influx across the brush border of rabbit ileum. Biochim Biophys Acta. 1970;211: 586-588.
8. Sigrist-Nelson K, Hopfer U. A distinct D-fructose transport system in isolated brush border membrane. Biochim Biophys Acta. 1974;367:247-254.
9. Mueckler M, Caruso C, Baldwin SA, et al. Sequence and structure of a human glucose transporter. Science. 1985;229: 941-945.
10. Manolescu AR, Witkowska K, Kinnaird A, et al. Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda). 2007;22:234-40.
11. Burant CF, Takeda J, Brot-Laroche E, et al. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem. 1992;267:14523-14526.
12. Davidson NO, Hausman AM, Ifkovits CA, et al. Human intestinal glucose transporter expression and localization of GLUT5. Am J Physiol. 1992;262(3 Pt 1):C795-C800.
13. Kane S, Seatter MJ, Gould GW. Functional studies of human GLUT5: effect of pH on substrate selection and an analysis of substrate interactions. Biochem Biophys Res Commun. 1997; 238:503-505.
14. Kayano T, Burant CF, Fukumoto H, et al. Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogenelike sequence (GLUT6). J Biol Chem. 1990;265:13276-13282.
15. Doege H, Bocianski A, Scheepers A, et al. Characterization of human glucose transporter (GLUT) 11 (encoded by SLC2A11), a novel sugar-transport facilitator specifically expressed in heart and skeletal muscle. Biochem J. 2001;359 (Pt 2):443-449.
16. Joost HG, Thorens B. The extended GLUT-family of sugar/ polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol. 2001;18:247-256.
17. Kim HR, Park SW, Cho HJ, et al. Comparative gene expression profiles of intestinal transporters in mice, rats and humans. Pharmacol Res. 2007;56:224-236.
18. Li Q, Manolescu A, Ritzel M, et al. Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine. Am J Physiol Gastrointest Liver Physiol. 2004;287:G236-G242.
19. Stuart CA, Howell ME, Yin D. Overexpression of GLUT5 in diabetic muscle is reversed by pioglitazone. Diabetes Care. 2007;30:925-931.
20. Boudry G, Cheeseman CI, Perdue MH. Psychological stress impairs Na+-dependent glucose absorption and increases GLUT2 expression in the rat jejunal brush-border membrane. Am J Physiol Regul Integr Comp Physiol. 2007;292:R862-R867.
21. Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes. 2005;54:3056-3062.
22. Shepherd EJ, Helliwell PA, Mace OJ, et al. Stress and glucocorticoid inhibit apical GLUT2-trafficking and intestinal glucose absorption in rat small intestine. J Physiol. 2004;560 (Pt 1):281-290.
23. Burant CF, Saxena M. Rapid reversible substrate regulation of fructose transporter expression in rat small intestine and kidney. Am J Physiol. 1994;267(1 Pt 1):G71-G79.
24. Douard V, Choi HI, Elshenawy S, et al. Developmental reprogramming of rat GLUT5 requires glucocorticoid receptor translocation to the nucleus. J Physiol. 2008;586(Pt 15):3657-3673.
25. Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab. 2008;295:E227-E237.
26. Jiang L, David ES, Espina N, et al. GLUT-5 expression in neonatal rats: crypt-villus location and age-dependent regulation. Am J Physiol Gastrointest Liver Physiol. 2001;281:G666-G674.
27. Mesonero J, Matosin M, Cambier D, et al. Sugar-dependent expression of the fructose transporter GLUT5 in Caco-2 cells. Biochem J. 1995;312(Pt 3):757-762.
28. Cui XL, Ananian C, Perez E, et al. Cyclic AMP stimulates fructose transport in neonatal rat small intestine. J Nutr. 2004; 134:1697-1703.
29. Holdsworth CD, Dawson AM. The absorption of monosaccharides in man. Clin Sci. 1964;27:371-379.
30. Rumessen JJ, Gudmand-Hoyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut. 1986;27:1161-1168.
31. Shi X, Schedl HP, Summers RM, et al. Fructose transport mechanisms in humans. Gastroenterology. 1997;113:1171-1179.
32. Hyams JS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints179. Gastroenterology. 1983;84:30-33.
33. Rumessen JJ, Gudmand-Hoyer E. Malabsorption of fructosesorbitol mixtures: interactions causing abdominal distress. Scand J Gastroenterol. 1987;22:431-436.
34. Symons P, Jones MP, Kellow JE. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructosesorbitol. Scand J Gastroenterol. 1992;27:940-944.
35. Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology. 1990;99:1016-1020.
36. Born P, Zech J, Lehn H, et al. Colonic bacterial activity determines the symptoms in people with fructose-malabsorption1. Hepatogastroenterology. 1995;42:778-785.
37. Rumessen JJ. Hydrogen and methane breath tests for evaluation of resistant carbohydrates. Eur J Clin Nutr. 1992;46(suppl 2):S77-S90.
38. Stone-Dorshow T, Levitt MD. Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener1. Am J Clin Nutr. 1987;46:61-65.
39. Rumessen JJ. Fructose and related food carbohydrates. Sources, intake, absorption, and clinical implications. Scand J Gastroenterol. 1992;27:819-828.
40. Spiller R. Role of motility in chronic diarrhoea. Neurogastroenterol Motil. 2006;18:1045-1055.
41. Madsen JL, Linnet J, Rumessen JJ. Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers. Dig Dis Sci. 2006;51:147-153.
42. Ropert A, Cherbut C, Roze C, et al. Colonic fermentation and proximal gastric tone in humans. Gastroenterology. 1996;111: 289-296.
43. Piche T, Zerbib F, Varannes SB et al. Modulation by colonic fermentation of LES function in humans. Am J Physiol Gastrointest Liver Physiol. 2000;278:G578-G584.
44. Piche T, des Varannes SB, Sacher-Huvelin S, et al. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology. 2003;124: 894-902.
45. Choi YK, Johlin FC Jr, Summers RW, et al. Fructose intolerance: an under-recognized problem. Am J Gastroenterol. 2003;98:1348-1353.
46. Rumessen JJ, Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology. 1988;95:694-700.
47. Fernandez-Banares F, Esteve-Pardo M, de LR, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol. 1993;88:2044-2050.
48. Johlin FC Jr, Panther M, Kraft N. Dietary fructose intolerance: diet modification can impact self-rated health and symptom control. Nutr Clin Care. 2004;7:92-97.
49. Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J. 2000;2:583-587.
50. Mishkin D, Sablauskas L, Yalovsky M, et al. Fructose and sorbitol malabsorption in ambulatory patients with functional dyspepsia: comparison with lactose maldigestion/malabsorption. Dig Dis Sci. 1997;42:2591-2598.
51. Choi YK, Kraft N, Zimmerman B, et al. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol. 2008;42:233-238.
52. Fernández-Banares F, Rosinach M, Esteve M, et al. Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr. 2006; 25:824-831.
53. Skoog SM, Bharucha AE, Zinsmeister AR. Comparison of breath testing with fructose and high fructose corn syrups in health and IBS. Neurogastroenterol Motil. 2008;20:505-511.
54. Calloway DH, Murphy EL, Bauer D. Determination of lactose intolerance by breath analysis. Am J Dig Dis. 1969;14:811-815.
55. Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med. 1969;281:122-127.
56. Thompson DG, Binfield P, De BA, et al. Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut. 1985;26: 1349-1352.
57. Metz G, Gassull MA, Drasar BS, et al. Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet. 1976;1: 668-669.
58. Valdovinos MA, Camilleri M, Thomforde GM, et al. Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol. 1993;28:963-968.
59. Sellin JH, Hart R. Glucose malabsorption associated with rapid intestinal transit. Am J Gastroenterol. 1992;87:584-589.
60. Corazza GR, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology. 1987;93:53-58.
61. Riordan SM, McIver CJ, Duncombe VM, et al. Factors influencing the 1-g 14C-D-xylose breath test for bacterial overgrowth. Am J Gastroenterol. 1995;90:1455-1460.
62. Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology. 1983;84: 26-29.
63. Truswell AS, Seach JM, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr. 1988;48:1424-1430.
64. Ladas SD, Grammenos I, Tassios PS, et al. Coincidental malabsorption of lactose, fructose, and sorbitol ingested at low doses is not common in normal adults. Dig Dis Sci. 2000;45: 2357-2362.
65. Rao SS, Attaluri A, Anderson L, et al. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol. 2007;5:959-963.
66. Karcher RE, Truding RM, Stawick LE. Using a cutoff of 10 ppm for breath hydrogen testing: a review of five years' experience. Ann Clin Lab Sci. 1999;29:1-8